BrightSpring Health Services (NASDAQ:BTSG) Price Target Raised to $20.00

BrightSpring Health Services (NASDAQ:BTSG) had its price target increased by UBS Group from $16.00 to $20.00 in a research report sent to investors on Wednesday morning, Benzinga reports. They currently have a buy rating on the stock.

Several other analysts have also recently weighed in on BTSG. KeyCorp began coverage on BrightSpring Health Services in a report on Friday, October 11th. They set a “sector weight” rating for the company. Guggenheim boosted their price target on shares of BrightSpring Health Services from $15.00 to $18.00 and gave the stock a “buy” rating in a research note on Tuesday, October 1st. The Goldman Sachs Group reduced their price objective on shares of BrightSpring Health Services from $21.00 to $18.00 and set a “buy” rating on the stock in a research note on Friday, August 9th. Finally, BTIG Research upped their target price on shares of BrightSpring Health Services from $15.00 to $20.00 and gave the company a “buy” rating in a research report on Thursday, October 3rd. One equities research analyst has rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, BrightSpring Health Services currently has a consensus rating of “Moderate Buy” and a consensus price target of $16.50.

BrightSpring Health Services Price Performance

BTSG opened at $17.25 on Wednesday. The company has a debt-to-equity ratio of 1.62, a current ratio of 1.33 and a quick ratio of 1.00. The company’s 50 day simple moving average is $14.48 and its 200-day simple moving average is $12.39. BrightSpring Health Services has a one year low of $7.85 and a one year high of $17.54.

BrightSpring Health Services (NASDAQ:BTSG) last announced its quarterly earnings data on Friday, November 1st. The company reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.07). The business had revenue of $2.91 billion during the quarter, compared to analysts’ expectations of $2.72 billion. The business’s revenue for the quarter was up 28.8% compared to the same quarter last year. Sell-side analysts anticipate that BrightSpring Health Services will post 0.57 EPS for the current fiscal year.

Insider Transactions at BrightSpring Health Services

In related news, major shareholder Kkr Group Partnership L.P. bought 11,619,998 shares of BrightSpring Health Services stock in a transaction that occurred on Wednesday, September 11th. The stock was purchased at an average cost of $11.13 per share, with a total value of $129,330,577.74. Following the purchase, the insider now owns 92,959,984 shares in the company, valued at approximately $1,034,644,621.92. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Hedge Funds Weigh In On BrightSpring Health Services

A number of large investors have recently bought and sold shares of BTSG. nVerses Capital LLC acquired a new position in BrightSpring Health Services during the second quarter worth $55,000. Ameritas Investment Partners Inc. bought a new position in shares of BrightSpring Health Services in the 1st quarter valued at about $58,000. California State Teachers Retirement System bought a new position in shares of BrightSpring Health Services in the 1st quarter valued at about $59,000. The Manufacturers Life Insurance Company raised its holdings in BrightSpring Health Services by 10.2% during the second quarter. The Manufacturers Life Insurance Company now owns 117,026 shares of the company’s stock worth $1,329,000 after acquiring an additional 10,854 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank acquired a new position in BrightSpring Health Services during the second quarter valued at approximately $126,000.

BrightSpring Health Services Company Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.